Patterns of treatment response in newly diagnosed epilepsy

Neurology

Volumn 78, Issue 20, 2012, Pages 1548-1554

  Brodie, M J ^a   Barry, S J E ^b   Bamagous, G A ^a   Norrie, J D ^c   Kwan, P ^d,e  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; TREATMENT RESPONSE; CHI SQUARE DISTRIBUTION; LONGITUDINAL STUDY; MIDDLE AGED; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; CHILD; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862314830     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182563b19     Document Type: Article

References (28)

1. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: A systematic review and meta-analysis. Neurology 2011;77:1005-1012.
2. Callaghan BC, Anand K, Hesdorffer D, Hauser WA, French JA. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007;62: 382-389.
3. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-381.
4. Choi H, Heiman G, Pandis D, et al. Seizure remission and relapse in adults with intractable epilepsy: A cohort study. Epilepsia 2008;49:1440-1445.
5. Schiller Y. Seizure relapse and development of drug resistance following long-term remission. Arch Neurol 2009; 66:1233-1239.
6. Sillanpäa M, Schmidt D. Natural history of treated childhood-onset epilepsy: Prospective long-term populationbased study. Brain 2006;129:617-624.
7. Berg AT, Levy SR, Testa FM, D'Souza R. Remission of epilepsy after failures in children: A prospective study. Ann Neurol 2009;65:510-519.
8. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: Results from the National General Practice Study of Epilepsy. Lancet 1995;346:140-144.
9. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
10. Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: Response to sequential treatment schedules. Eur J Neurol 2006;13:277-282.
11. Stephen LJ, Brodie MJ. Selection of antiepileptic drugs in adults. Neurol Clin 2009;27:967-992.
12. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epilepsy seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-472.
13. Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002;58(suppl 5):S2-S8.
14. Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs: Best practice guidelines for therapeutic drug monitoring: A position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-1276.
15. French JA, Pedley TA. Initial management of epilepsy. N Engl J Med 2008;359:166-176.
16. Kwan P, Brodie MJ. Combination therapy in epilepsy: When and what to use. Drugs 2006;66:1817-1829.
17. Commission on classification and terminology of the ILAE: Proposal for revised clinical classification of epileptic seizures. Epilepsia 1981;22:489-501.
18. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsy and epileptic syndromes. Epilepsia 1989;30:389-399.
19. Klein JP, Moeschberger ML. Survival analysis: Techniques for censored and truncated data, 2nd ed. New York: Springer-Verlag; 2003.
20. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16: 1141-1154.
21. Callaghan B, Schlesinger M, Rodemer W, et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia 2011;52:619-626.
22. Choi H, Heiman GA, Clary HM, Etienne M, Resor SR, Hauser WA. Seizure remission in adults with longstanding intractable epilepsy: An extended follow-up. Epilepsy Res 2011;93:115-119.
23. Dichter MA. Emerging concepts in the pathogenesis of epilepsy and epileptogenesis. Arch Neurol 2009;66:443-447.
24. Engel J Jr, Wiebe S, French J, et al. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy. Epilepsia 2003;44:741-751.
25. Schiller Y, Najjar Y. Quantifying response to antiepileptic drugs: Effect of past treatment history. Neurology 2008;70: 54-65.
26. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;50:1069-1077.
27. Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Epilepsia 2011;52:657-678.
28. Kwan P, Brodie MJ. Definition of refractory epilepsy: Defining the indefinable? Lancet Neurol 2010;9:27-29.